Biotech is showing early signs of life after a prolonged funding winter, but for many early-stage companies, conditions remain unforgiving. Years of low valuations, high borrowing costs and regulatory uncertainty have reshaped investor behaviour, with capital scarce...

The life sciences sector sits at the intersection of discovery, technology and human impact. From developing new medicines and diagnostics to advancing environmental sustainability and digital health, careers in life sciences offer the chance to work on problems that...

For decades, obesity has been defined and diagnosed primarily using body mass index (BMI), a simple ratio of weight to height. While BMI has been widely adopted for its convenience and scalability, a growing body of research now suggests that it may be an incomplete...

Spinal cord injuries remain one of the most challenging conditions in modern medicine. Damage to the spinal cord often leads to permanent paralysis, loss of sensation, and a dramatic decline in quality of life. For decades, treatment options have been limited to...

Basecamp Research, a frontier AI lab harnessing evolution to design new medicines, today announced the first AI models capable of programmable gene insertion, offering a new way to replace faulty genes and reprogram cells for therapeutic use. Trained in collaboration...

Peptides are no longer confined to the margins of biomedical research. Once viewed primarily as niche tools for probing biological pathways or as incremental drug candidates, peptides and related biomolecules are now emerging as a central pillar of innovation across...